ABCG2 p.Cys55Ala

Predicted by SNAP2: A: N (72%), D: N (53%), E: N (57%), F: N (82%), G: N (78%), H: N (87%), I: N (78%), K: N (66%), L: N (82%), M: N (66%), N: N (78%), P: N (57%), Q: N (78%), R: N (78%), S: N (82%), T: N (78%), V: N (78%), W: N (72%), Y: N (82%),
Predicted by PROVEAN: A: N, D: D, E: D, F: D, G: D, H: D, I: D, K: D, L: D, M: D, N: D, P: D, Q: D, R: D, S: N, T: D, V: D, W: D, Y: D,

[switch to compact view]
Comments [show]
Publications
[hide] Deeken JF, Figg WD, Bates SE, Sparreboom A
Toward individualized treatment: prediction of anticancer drug disposition and toxicity with pharmacogenetics.
Anticancer Drugs. 2007 Feb;18(2):111-26., [PMID:17159598] [PubMed]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Liu Y, Yang Y, Qi J, Peng H, Zhang JT
Effect of cysteine mutagenesis on the function and disulfide bond formation of human ABCG2.
J Pharmacol Exp Ther. 2008 Jul;326(1):33-40. Epub 2008 Apr 22., [PMID:18430864] [PubMed]

Abstract [show]
Comments [show]
Sentences [show]